Agravis Poaches Customers as BayWa’s Restructuring Hits a Triple Deadlock

BayWa’s restructuring is colliding with reality on three fronts: a blocked asset sale, a deepening rift between creditors and shareholders, and a resurgent rival already picking off disgruntled farmers. With a €2.7 billion hole to plug by autumn 2026, the agricultural giant is running out of room for error.

The immediate pressure point is T&G Global, the New Zealand apple marketer behind the Envy and Jazz brands. Goldman Sachs has been shopping BayWa’s 74% stake since March 2026, hoping to raise roughly €300 million – a sum baked into the restructuring plan. But Hong Kong-based minority shareholder Joy Wing Mau Group, which holds nearly 20%, is dragging its feet. Until the sale closes, that cash wedge remains out of reach.

The standoff extends to BayWa’s capital structure itself. DZ Bank and UniCredit (HVB) are demanding that the cooperative shareholders – primarily the Bavarian Volks- und Raiffeisenbanken – inject fresh equity. The cooperatives have refused. The two largest owners, Bayerische Raiffeisen-Beteiligungs-AG (36.5%) and Austria’s Raiffeisen Agrar Invest (30.6%), are pushing back, arguing the banks should shoulder more of the burden. A proposed trust model to bundle creditor interests has yet to win unanimous support, leaving the entire financing plan vulnerable.

Meanwhile, the clock is set by three interdependent deadlines, all due by autumn. BayWa must file a certified annual report for 2025, secure an extension of its standstill agreement with core banks, and complete the T&G sale. Missing any single one of these would collapse the legal basis for the turnaround. The 2025 accounts are already delayed because the restructuring plan is still being overhauled, leaving investors flying blind on valuation.

Should investors sell immediately? Or is it worth buying BayWa?

Operationally, BayWa is deliberately shrinking. First-quarter 2026 revenue fell to €2.3 billion from €3.6 billion a year earlier – a 35% drop that partly reflects asset disposals. The adjusted EBITDA came in above the restructuring plan’s targets, though the company won’t disclose absolute profit figures while the plan is under revision. To cut debt, the group aims to pare annual sales to €10 billion by 2028, close two Bavarian sites (Hersbruck and Regen) with three more slated for 2026 and further closures in 2027, and eliminate 1,300 jobs. Creditors are being asked to accept write-offs of roughly €1 billion, possibly via betterment certificates that revive claims if the business recovers.

That shrinkage is creating an opening for competitors. Agravis Raiffeisen, a German agricultural trading house traditionally strong in the north and east, is actively approaching farm cooperatives in Bavaria and Baden-Württemberg – BayWa’s home turf. The push centers on wholesale seed, fertilizer and crop protection, as well as grain, maize and rapeseed procurement. A survey from the Bayerisches Landwirtschaftliches Wochenblatt published in January found nearly half of farmers had lost confidence in BayWa and would no longer market their harvest through the group. Agravis is stepping into that void.

The stock, which closed Friday at €12.25, has lost nearly 27% since the start of the year. The annualized 30-day volatility of 107% underscores how binary the outcome feels ahead of the autumn deadlines. Legal risks are piling up as well: law firm TILP is organizing shareholder damage claims based on a BaFin reprimand over missing disclosure in the 2023 management report, and Munich prosecutors are investigating former CEOs Klaus Josef Lutz and Marcus Pöllinger – both of whom maintain their innocence.

BayWa at a turning point? This analysis reveals what investors need to know now.

Whether the trust model can bridge the gap between the banks and the cooperative shareholders remains the key variable. Absent a deal, the restructuring’s foundation will fall away, leaving BayWa’s creditors, employees and customers to reckon with the fallout of a collapse that no longer seems unthinkable.

Ad

BayWa Stock: New Analysis - 7 June

Fresh BayWa information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BayWa analysis...

en | DE0005194005 | AGRAVIS | boerse | 69496623 |